# Autoeczematization: A Rare Complication of Contact Dermatitis Triggered by Topical Antibiotic Ointment

**Authors:** George Miura, Norihiro Yoshimoto, Suguru Kurosawa, Hiroyuki Nakamura

PMC · DOI: 10.7759/cureus.100040 · Cureus · 2025-12-24

## TL;DR

A man developed a rare skin reaction called autoeczematization after using a topical antibiotic ointment, highlighting the importance of recognizing this complication.

## Contribution

This case report highlights autoeczematization as a rare but important complication of topical antibiotic use.

## Key findings

- A 42-year-old man developed generalized exudative erythematous papules after using Baramycin® ointment.
- Discontinuation of the ointment and treatment with clobetasol propionate led to resolution of symptoms.
- The case suggests allergic contact dermatitis with secondary autoeczematization.

## Abstract

Topical antibiotic ointments are widely prescribed for infection prophylaxis after surgery and trauma, yet they are an important cause of allergic contact dermatitis. Autoeczematization, or id reaction, refers to secondary eczematous eruptions that arise at sites distant from a primary localized inflammatory focus.

We report a 42-year-old man who developed generalized exudative erythematous papules after application of Baramycin® (bacitracin and fradiomycin sulfate) ointment to an erosion on his right lower leg treated for cellulitis. Despite improvement of systemic inflammatory markers, well-demarcated erythema confined to the area of ointment and dressing use, accompanied by widespread papules on the trunk, face, and extremities, persisted. Delayed patch testing could have been performed after clinical improvement, but the patient was lost to follow-up, and the clinical course strongly suggested allergic contact dermatitis with secondary autoeczematization.

Discontinuation of Baramycin® and initiation of topical clobetasol propionate led to the gradual resolution of the primary lesion and rapid improvement of distant eruptions. This case underscores the need to consider autoeczematization in patients presenting with diffuse eczematous eruptions following the use of topical antibiotics.

## Linked entities

- **Chemicals:** bacitracin (PubChem CID 10909430), fradiomycin sulfate (PubChem CID 197162), clobetasol propionate (PubChem CID 32798)
- **Diseases:** cellulitis (MONDO:0005230), allergic contact dermatitis (MONDO:0006525)

## Full-text entities

- **Diseases:** eruptions (MESH:D003875), allergic contact dermatitis (MESH:D017449), infection (MESH:D007239), erythema (MESH:D004890), erythematous papules (MESH:D000169), Contact Dermatitis (MESH:D003877), inflammatory (MESH:D007249), cellulitis (MESH:D002481), eczematous eruptions (MESH:D017443), trauma (MESH:D014947)
- **Chemicals:** Baramycin (-), bacitracin (MESH:D001414), fradiomycin sulfate (MESH:D009355), clobetasol propionate (MESH:D002990)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12831036/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12831036/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12831036/full.md

---
Source: https://tomesphere.com/paper/PMC12831036